KIT and mast cell neoplasm: In conclusion, the present study showed that AQ1 G4-binding compound inhibited KIT expression and its downstream signaling molecules GRB2, AKT and FYN in two in vitro models of human and canine mast cell neoplasms (HMC1.2 and C2 cells).